Condition
Wet AMD clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Wet AMD clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Ixo-vec gene therapy versus aflibercept for wet age-related macular degeneration (AQUARIUS)
This study tests whether a single injection of Ixo-vec gene therapy can maintain or improve vision as well as regular aflibercept injections in adults aged 50 and older with active neovascular (wet) AMD.
-
LX102 gene therapy for neovascular (wet) age-related macular degeneration
This trial will test whether a single subretinal injection of LX102 gene therapy can maintain or improve vision in people aged 50–80 with active neovascular (wet) AMD who previously responded to aflibercept.
Related topics
Quick answers
How many Wet AMD clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.